Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kelch-like protein 22 is a BTB-Kelch family adaptor protein that forms a functional cullin 3-RING E3 ubiquitin ligase complex (BTB-CUL3-RBX1). It mediates ubiquitin-dependent regulation of target proteins, notably monoubiquitination of Polo-like kinase 1 (PLK1), critical for regulation of spindle assembly checkpoint and proper chromosome segregation during mitosis. KLHL22 also regulates proteasomal degradation of DEPDC5, leading to mTORC1 pathway activation, thereby influencing cell growth, autophagy, and potentially tumorigenesis and cellular aging. KLHL22 overexpression correlates with poor prognosis in triple-negative breast cancer, and its expression serves as an independent prognostic marker for disease progression and survival. KLHL22 is primarily localized to the cytoplasm and is involved in the regulation of the spindle assembly checkpoint and cellular response to nutrient cues, affecting broad biological processes across different tissues.
Not applicable, as no KLHL22-targeting drugs are established; however, it mediates monoubiquitination and polyubiquitination of key substrates (e.g., PLK1, DEPDC5) via E3 ubiquitin ligase complex function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch-like protein 22 (KLHL22).